CRYSTALLINE RET INHIBITOR
Provided herein is a crystalline form of selpercatinib useful in the treatment and prevention of diseases which can be treated with a RET kinase inhibitor, including RET-associated diseases and disorders, and methods of making this crystalline form. La présente invention concerne une forme cristalli...
Gespeichert in:
| Hauptverfasser: | , , , , , |
|---|---|
| Format: | Patent |
| Sprache: | eng ; fre |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | |
| container_title | |
| container_volume | |
| creator | MERRITT, JEREMY MILES BHARDWAJ, RAJNI MIGLANI KERR, MARK STEVEN KJELL, DOUGLAS PATTON VISWANATH, SHEKHAR KRISHNA SELBO, JON GORDON |
| description | Provided herein is a crystalline form of selpercatinib useful in the treatment and prevention of diseases which can be treated with a RET kinase inhibitor, including RET-associated diseases and disorders, and methods of making this crystalline form.
La présente invention concerne une forme cristalline de selpercatinib utile dans le traitement et la prévention de maladies qui peuvent être traitées avec un inhibiteur de kinase RET, y compris des maladies et des troubles associés à RET, et des procédés de production de cette forme cristalline. |
| format | Patent |
| fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_CA3174316A1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>CA3174316A1</sourcerecordid><originalsourceid>FETCH-epo_espacenet_CA3174316A13</originalsourceid><addsrcrecordid>eNrjZJB0DooMDnH08fH0c1UIcg1R8PTz8HTyDPEP4mFgTUvMKU7lhdLcDApuriHOHrqpBfnxqcUFicmpeakl8c6OxobmJsaGZo6GxkQoAQDhnx-V</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>CRYSTALLINE RET INHIBITOR</title><source>esp@cenet</source><creator>MERRITT, JEREMY MILES ; BHARDWAJ, RAJNI MIGLANI ; KERR, MARK STEVEN ; KJELL, DOUGLAS PATTON ; VISWANATH, SHEKHAR KRISHNA ; SELBO, JON GORDON</creator><creatorcontrib>MERRITT, JEREMY MILES ; BHARDWAJ, RAJNI MIGLANI ; KERR, MARK STEVEN ; KJELL, DOUGLAS PATTON ; VISWANATH, SHEKHAR KRISHNA ; SELBO, JON GORDON</creatorcontrib><description>Provided herein is a crystalline form of selpercatinib useful in the treatment and prevention of diseases which can be treated with a RET kinase inhibitor, including RET-associated diseases and disorders, and methods of making this crystalline form.
La présente invention concerne une forme cristalline de selpercatinib utile dans le traitement et la prévention de maladies qui peuvent être traitées avec un inhibiteur de kinase RET, y compris des maladies et des troubles associés à RET, et des procédés de production de cette forme cristalline.</description><language>eng ; fre</language><subject>CHEMISTRY ; HETEROCYCLIC COMPOUNDS ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2021</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20211021&DB=EPODOC&CC=CA&NR=3174316A1$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,776,881,25543,76293</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20211021&DB=EPODOC&CC=CA&NR=3174316A1$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>MERRITT, JEREMY MILES</creatorcontrib><creatorcontrib>BHARDWAJ, RAJNI MIGLANI</creatorcontrib><creatorcontrib>KERR, MARK STEVEN</creatorcontrib><creatorcontrib>KJELL, DOUGLAS PATTON</creatorcontrib><creatorcontrib>VISWANATH, SHEKHAR KRISHNA</creatorcontrib><creatorcontrib>SELBO, JON GORDON</creatorcontrib><title>CRYSTALLINE RET INHIBITOR</title><description>Provided herein is a crystalline form of selpercatinib useful in the treatment and prevention of diseases which can be treated with a RET kinase inhibitor, including RET-associated diseases and disorders, and methods of making this crystalline form.
La présente invention concerne une forme cristalline de selpercatinib utile dans le traitement et la prévention de maladies qui peuvent être traitées avec un inhibiteur de kinase RET, y compris des maladies et des troubles associés à RET, et des procédés de production de cette forme cristalline.</description><subject>CHEMISTRY</subject><subject>HETEROCYCLIC COMPOUNDS</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2021</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZJB0DooMDnH08fH0c1UIcg1R8PTz8HTyDPEP4mFgTUvMKU7lhdLcDApuriHOHrqpBfnxqcUFicmpeakl8c6OxobmJsaGZo6GxkQoAQDhnx-V</recordid><startdate>20211021</startdate><enddate>20211021</enddate><creator>MERRITT, JEREMY MILES</creator><creator>BHARDWAJ, RAJNI MIGLANI</creator><creator>KERR, MARK STEVEN</creator><creator>KJELL, DOUGLAS PATTON</creator><creator>VISWANATH, SHEKHAR KRISHNA</creator><creator>SELBO, JON GORDON</creator><scope>EVB</scope></search><sort><creationdate>20211021</creationdate><title>CRYSTALLINE RET INHIBITOR</title><author>MERRITT, JEREMY MILES ; BHARDWAJ, RAJNI MIGLANI ; KERR, MARK STEVEN ; KJELL, DOUGLAS PATTON ; VISWANATH, SHEKHAR KRISHNA ; SELBO, JON GORDON</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_CA3174316A13</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; fre</language><creationdate>2021</creationdate><topic>CHEMISTRY</topic><topic>HETEROCYCLIC COMPOUNDS</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>MERRITT, JEREMY MILES</creatorcontrib><creatorcontrib>BHARDWAJ, RAJNI MIGLANI</creatorcontrib><creatorcontrib>KERR, MARK STEVEN</creatorcontrib><creatorcontrib>KJELL, DOUGLAS PATTON</creatorcontrib><creatorcontrib>VISWANATH, SHEKHAR KRISHNA</creatorcontrib><creatorcontrib>SELBO, JON GORDON</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>MERRITT, JEREMY MILES</au><au>BHARDWAJ, RAJNI MIGLANI</au><au>KERR, MARK STEVEN</au><au>KJELL, DOUGLAS PATTON</au><au>VISWANATH, SHEKHAR KRISHNA</au><au>SELBO, JON GORDON</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>CRYSTALLINE RET INHIBITOR</title><date>2021-10-21</date><risdate>2021</risdate><abstract>Provided herein is a crystalline form of selpercatinib useful in the treatment and prevention of diseases which can be treated with a RET kinase inhibitor, including RET-associated diseases and disorders, and methods of making this crystalline form.
La présente invention concerne une forme cristalline de selpercatinib utile dans le traitement et la prévention de maladies qui peuvent être traitées avec un inhibiteur de kinase RET, y compris des maladies et des troubles associés à RET, et des procédés de production de cette forme cristalline.</abstract><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | |
| ispartof | |
| issn | |
| language | eng ; fre |
| recordid | cdi_epo_espacenet_CA3174316A1 |
| source | esp@cenet |
| subjects | CHEMISTRY HETEROCYCLIC COMPOUNDS HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS |
| title | CRYSTALLINE RET INHIBITOR |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-24T12%3A14%3A50IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=MERRITT,%20JEREMY%20MILES&rft.date=2021-10-21&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3ECA3174316A1%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |